Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: stellerstar who wrote (570)	10/19/1998 10:11:00 AM
From: DavidCG	Read Replies (2) \| Respond to of 1255

Sue, I just want you to understand that human studies to be completely finished would take probably a few years. Phase I is where they test for safety of the drug on a very small number of patients (maybe 20-30). To make sure there aren't really horrible side effects and what not. If it passes this stage....then onward to Phase II is where they test on a larger group of patients. I believe this is where they test it to see how effective it is. (maybe 60-90) Phase III is the largest group of patients. (maybe 600-900) If it passes all three phases with great results, then it goes to the FDA advisory board. If they like it, it goes to the FDA for approval. But you are right, if you believe in this drug, and understand the risks of waiting (as anything can happen at each one of these steps).... now is a good time to buy CORX. -DavidCG